William M. Blackshear, Jr., M.D., on behalf of Prescription Health Network, LLC, filed on May 14, 2015; The Petitioner seeks a Declaratory Statement from the Board with regard to Rule 64B16-27.700, Florida Administrative Code, as to whether the ...

 

DEPARTMENT OF HEALTH

Board of Pharmacy

RULE NO.:RULE TITLE:

64B16-27.700Definition of Compounding

NOTICE IS HEREBY GIVEN that Board of Pharmacy has received the petition for declaratory statement from William M. Blackshear, Jr., M.D., on behalf of Prescription Health Network, LLC, filed on May 14, 2015. The petition seeks the agency’s opinion as to the applicability of Rule 64B16-27.700, F.A.C., as it applies to the petitioner.

The Petitioner seeks a Declaratory Statement from the Board with regard to Rule 64B16-27.700, F.A.C., as to whether the ingredients used in the company’s weight loss injections, as described and outlined in the petition, fall under the restrictions placed on office use of compounding drugs. Except for good cause shown, motions for leave to intervene must be filed within 21 days after the publication of this notice.

A copy of the Petition for Declaratory Statement may be obtained by contacting: Allison Dudley, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin #C04, Tallahassee, Florida 32399-3254 or by email: [e-mail].